Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Lasa Supergenerics

Sector: Healthcare | Industry: Drugs & Pharma
R 17.45 0.00  | 0.00% -15.09% - 39.56
NSE Price: Oct 15, 15:32 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:32 17.45 0.00 0.00% 17.45 17.45 14,293 17.45 - 17.75
BSE Oct 15, 2019 17.30 0.00 0.00% 17.65 17.30 3,631 17.30 - 17.75
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 38,769 P/B: 0.38 NSE Code: LASA
52-Week Range: R 9.45 - 36.55 Dividend Yield: 0.00% BSE Code: 540702
TTM EPS: R -4.43 Book Value: R 45.58 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Lasa Supergenerics -42.12 0.29 71.08 -15.09 - - -
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of NSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -30.37 - -
Net Profit -197.49 - -
EPS -197.49 - -
Book Value -10.26 40.36 -
Average
Operating Margin 8.98 17.12 -
Net Margin -6.92 -0.25 -
Return on Networth -10.81 4.06 -
Return on Investment -1.97 8.43 -
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -7.23 18.42 -7.23
Operating Profit 20.54 -2.51 20.54
Net Profit 40.22 63.84 40.22
EPS 40.23 63.84 40.23
TTM
Revenue 3.58 -19.34 3.58
Operating Profit -0.93 -63.66 -0.93
Net Profit 15.79 -230.27 15.79
EPS 15.79 -230.27 15.79
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Lasa Supergenerics 39.56 175.64 -10.13 -5.67 -10.81 0.38 -
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 18, 2018 Omkar Herlekar  Buy Off Market 1,100,000 42.55 468.05
Jun 18, 2018 Pravin Herlekar  Sell Inter-Se Transfer 1,100,000 42.55 468.05
Apr 26, 2018 Omkar Speciality Chemicals Ltd  Sell Off Market 1,100,000 81.80 899.80
Apr 26, 2018 Pravin Herlekar  Buy Off Market 1,100,000 81.80 899.80
Apr 26, 2018 Pravin Shivdas Herlekar  Sell Sale 236,314 81.80 193.30
News & Announcements
Contact Information

Company: Lasa Supergenerics Ltd.

Address: C-105, M I D C, Mahad, Raigad Dist, Maharashtra - 402309 | Phone: 02145 232101/232202

Email: [email protected]

Website: www.lasalabs.com

Registrar & Transfer Agent: Bigshare Services Pvt Ltd

Address: Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: +91 21 62638299(Old Address) E-2&3 , Ansa Industrial Estate,Saki Vihar Road,Saki Naka, Andheri (E),Mumbai, Bharat Tin Works Building, 1st floor, Opp. Vasant Oasis, Andheri (E) | Phone: 91-022-62638200 | Fax: 91-022-62638299

Email: [email protected]

Essential checks
Altman Z-Score
1.12
Piotroski F-Score
4
Modified C-Score
4
1-Year Price to Earnings
Not applicable
1-Year Price to Book
0.38
Earnings Yield
EBIT / Enterprise value
-3.83%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59